6

Viemed Healthcare (VMD-T)

ON STOCKCHASE SINCE Jul 2018

0

Viemed Healthcare
VMD-T

16 watching

Join the Discussion

Expert Opinions
0 comments
Your Reaction

0 0 0 0 0

What the experts are saying about VMD-T

Signal	Opinion	Expert
WEAK BUY	Viemed Healthcare(VMD-T) April 17, 2019 Small company. Market cap around $250 mill. Not very followed. Decent growth on the revenue side of around 40%. Still have to spend that money. The regulatory issues are big. Very competitive space. But they are very good at it. 0 0 0 0 0 0 comments	Small company. Market cap around $250 mill. Not very followed. Decent growth on the revenue side of around 40%. Still have to spend that money. The regulatory issues are big. Very competitive space. But they are very good at it. 0 0 0 0 0 0 0 comments Kim Bolton President , Black Swan Dexterita... Price $7.350 Owned No

STRONG BUY	Viemed Healthcare(VMD-T) April 4, 2019 He almost made it a Top Pick this time. It is a great company and he continues to love it. They were a former sleep management company and are now in the sleep apnea and oxygen space. He adds when the stock sells off. Over time it will continue to higher until it gets taken out. 0 0 0 0 0 0 comments	He almost made it a Top Pick this time. It is a great company and he continues to love it. They were a former sleep management company and are now in the sleep apnea and oxygen space. He adds when the stock sells off. Over time it will continue to higher until it gets taken out. 0 0 0 0 0 0 0 comments Bruce Campbell President , Stone Castle Investm... Price $7.010 Owned Yes
COMMENT	Viemed Healthcare(VMD-T) January 21, 2019 Took a beating from $8 to $4 upon news about a regulatory change that effected their medical products. He sold his shares. They rely on medicaid and Medicare, but he'd rather see them diversify their revenue base (which they're talking about doing). Good managers, though; he's met them. VMD was too volatile for him. If you own this and can stomach this volatility, VMD will eventually supply a good return. 0 0 0 0 0 0 comments	Took a beating from $8 to $4 upon news about a regulatory change that effected their medical products. He sold his shares. They rely on medicaid and Medicare, but he'd rather see them diversify their revenue base (which they're talking about doing). Good managers, though; he's met them. VMD was too volatile for him. If you own this and can stomach this volatility, VMD will eventually supply a good return. 0 0 0 0 0 0 0 comments Jason Del Vicar Portfolio , HollisWealth... Price $5.360 Owned No
BUY	Viemed Healthcare(VMD-T) October 4, 2018 They are an interesting company, spun out of the PHM-X group. They have been executing very well. There was a study that looked at what happens when people are closely monitored and it was very in favour in terms of what Biomed does. This is home monitoring of the COPD disease so they can push them out of hospitals sooner. They were growing at 20% per year organically. He continues to own it. PHM-X also looks really attractive now. 0 0 0 0 0 0 comments	They are an interesting company, spun out of the PHM-X group. They have been executing very well. There was a study that looked at what happens when people are closely monitored and it was very in favour in terms of what Biomed does. This is home monitoring of the COPD disease so they can push them out of hospitals sooner. They were growing at 20% per year organically. He continues to own it. PHM-X also looks really attractive now. 0 0 0 0 0 0 0 comments Bruce Campbell President , Stone Castle Investm... Price $7.110 Owned Yes
TOP PICK	Viemed Healthcare(VMD-T) September 24, 2018 They're the number three player in U.S. respiratory providers. They were spun out of Patient Home Monitoring. 30% ROE. As long as they execute and grow organically, their stock price will rise in 1-2 years. (no dividend, Anaylsts' price target: $9.75) 0 0 0 0 0 0 comments	They're the number three player in U.S. respiratory providers. They were spun out of Patient Home Monitoring. 30% ROE. As long as they execute and grow organically, their stock price will rise in 1-2 years. (no dividend, Anaylsts' price target: $9.75) 0 0 0 0 0 0 0 comments Jason Del Vicar Portfolio , HollisWealth... Price $6.450 Owned Yes
BUY	Viemed Healthcare(VMD-T) July 24, 2018 Provides breathing masks and other respiratory support services. He expects significant growth and sees it as reasonably priced relative to projected earnings. 0 0 0 0 0 0 comments	Provides breathing masks and other respiratory support services. He expects significant growth and sees it as reasonably priced relative to projected earnings. 0 0 0 0 0 0 0 comments Robert McWhirte President, Selective Asset Mana... Price $4.530 Owned No

4+

JOIN THE DISCUSSION
4 comments in the last 7 days

Stockchase, in its reporting on what has been discussed by indviduals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

© Stockchase Inc. & Wealthica Financial Technology Inc.